Price Alert

Novartis AG (NVSEF)

OTC: NVSEF · Real-Time Price · USD

120.78

5.28 (4.57%)

At close: Aug 15, 2025, 1:24 PM

115.50

-4.37%

After-hours: Aug 13, 2025, 08:00 PM EDT

Novartis Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	55.19B	52.94B	50.78B	49B	47.92B	49.27B	51.01B	52.32B	53.07B	52.22B	51.83B	52.26B	52.79B	53B	52.88B	52.38B	51.56B	49.88B
Cost of Revenue	13.11B	13.02B	12.83B	12.53B	12.41B	13.51B	14.41B	15.46B	16.15B	15.56B	15.49B	15.39B	15.52B	15.68B	15.87B	16.11B	15.92B	15.44B
Gross Profit	42.08B	39.92B	37.95B	36.47B	35.51B	35.76B	36.6B	36.86B	36.92B	36.66B	36.34B	36.87B	37.27B	37.31B	37.01B	36.28B	35.63B	34.45B
Operating Income	16.68B	15.76B	14.63B	13.68B	11.81B	10.78B	10.12B	9.49B	9.89B	9.2B	9.2B	9.81B	10.88B	12.13B	11.69B	11.77B	10.95B	9.82B
Interest Income	317M	392M	398M	107M	88.25M	88.25M	186.25M	186.25M	179M	120M	36M	36M	36M	20M	n/a	n/a	n/a	n/a
Pretax Income	15.68B	15.01B	13.6B	12.69B	10.86B	9.76B	9.44B	8.8B	9.17B	8.44B	8.37B	23.58B	24.89B	26.36B	26.14B	11.74B	10.93B	9.71B
Net Income	13.71B	12.91B	11.94B	17.6B	16.18B	15.24B	14.85B	7.84B	7.65B	7.03B	6.96B	21.8B	22.98B	24.18B	24.02B	9.81B	8.98B	7.96B
Selling & General & Admin	13.13B	12.8B	12.5B	12.44B	12.4B	12.97B	13.66B	13.97B	14.29B	14.18B	14.25B	14.49B	14.7B	14.87B	14.89B	14.82B	14.63B	14.24B
Research & Development	10.33B	9.89B	9.69B	9.41B	10.94B	11.18B	11.81B	11.69B	10.5B	10.47B	10B	9.96B	9.61B	9.51B	9.54B	9.46B	9.23B	9.27B
Other Expenses	1.93B	1.45B	1.15B	785M	n/a	n/a	n/a	35.45M	63.83M	136.51M	203.55M	170.13M	217.54M	241.38M	174.35M	172.33M	96.52M	n/a
Operating Expenses	25.39B	24.14B	23.33B	22.8B	23.7B	24.97B	26.48B	27.37B	27.03B	27.46B	27.14B	27.06B	26.39B	25.19B	25.32B	24.51B	24.68B	24.62B
Interest Expense	1.11B	1.06B	1.01B	948M	906M	884M	863M	865M	849M	827M	828M	744M	740M	739M	740M	715M	722M	741M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	38.5B	37.17B	36.16B	35.32B	36.11B	38.49B	40.89B	42.84B	43.18B	43.02B	42.63B	42.45B	41.91B	40.87B	41.19B	40.61B	40.61B	40.06B
Income Tax Expense	1.98B	2.07B	1.69B	965.03M	804.03M	657.43M	676M	1.21B	1.52B	1.41B	1.42B	1.79B	1.91B	2.18B	2.12B	1.93B	1.94B	1.75B
Shares Outstanding (Basic)	1.95B	1.97B	1.99B	2.01B	2.03B	2.04B	2.05B	2.06B	2.08B	2.11B	2.13B	2.17B	2.2B	2.23B	2.24B	2.24B	2.24B	2.25B
Shares Outstanding (Diluted)	1.96B	1.98B	2B	2.03B	2.05B	2.06B	2.06B	2.08B	2.1B	2.12B	2.15B	2.18B	2.21B	2.24B	2.25B	2.25B	2.26B	2.27B
EPS (Basic)	6.90	6.44	5.88	8.82	8.06	7.57	7.40	3.76	3.67	3.32	3.22	9.79	10.29	10.81	10.72	4.35	3.97	3.50
EPS (Diluted)	6.86	6.40	5.85	8.77	8.02	7.53	7.35	3.73	3.63	3.29	3.19	9.72	10.22	10.73	10.65	4.33	3.95	3.48
EBITDA	22.71B	21.75B	20.47B	19.72B	18.99B	18.68B	18.73B	18.37B	17.56B	16.83B	16.51B	31.11B	31.62B	32.38B	32.45B	18.15B	17.92B	17.29B
EBIT	16.71B	15.97B	14.57B	13.77B	11.89B	10.7B	10.14B	9.43B	9.75B	9.12B	9.27B	24.39B	25.45B	26.6B	26.38B	11.99B	11.45B	10.54B
Depreciation & Amortization	6B	5.92B	6.04B	6.08B	7.12B	7.78B	8.52B	8.88B	7.86B	7.85B	7.24B	6.74B	6.19B	5.79B	6.08B	6.17B	6.47B	6.75B